alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › detection

detection

7 studies tagged detection, dated 2014-12-26 to 2026-01-05. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. A minimally invasive dried blood spot biomarker test for the detection of Alzheimer's disease pathology 2026-01-05
  2. Association and multimodal model of retinal and blood-based biomarkers for detection of preclinical Alzheimer's disease 2025-01-10
  3. Immunoassay detection of multiphosphorylated tau proteoforms as cerebrospinal fluid and plasma Alzheimer's disease biomarkers 2025-01-02

Studies

7 studies carry this tag.

Date range

2014 to 2026

Top journals

  • Alzheimer's research & therapy 1
  • Bioelectrochemistry (Amsterdam, Netherlands) 1
  • Biosensors & bioelectronics 1
  • Nature communications 1
  • Nature medicine 1

7 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. A minimally invasive dried blood spot biomarker test for the detection of Alzheimer's disease pathology

    ✓ Peer-reviewed alzhub usefulness score 60 out of 100. Nature medicine 2026-01-05 Biomarkers

    Blood biomarkers have emerged as accurate tools for detecting Alzheimer's disease (AD) pathology, offering a minimally invasive alternative to traditional diagnostic methods such as imaging and cerebrospinal fluid (CSF) analysis.

  2. Association and multimodal model of retinal and blood-based biomarkers for detection of preclinical Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 55 out of 100. Alzheimer's research & therapy 2025-01-10 Biomarkers

    A subgroup cohort of 57 eyes from 32 participants with recent Aβ positron emission tomography (PET) results, comprising 18 preclinical patients (Aβ PET + ve, 32 eyes) and 14 controls (Aβ PET -ve, 25 eyes) with a mean age of 69 vs. 66, p = 0.06, was included for the assessment of a multimodal model to distinguish between the two groups.

  3. Immunoassay detection of multiphosphorylated tau proteoforms as cerebrospinal fluid and plasma Alzheimer's disease biomarkers

    ✓ Peer-reviewed alzhub usefulness score 55 out of 100. Nature communications 2025-01-02 Biomarkers

    Different forms of phosphorylated tau (p-tau) have shown strong potential as Alzheimer's disease (AD) biomarkers in both cerebrospinal fluid (CSF) and plasma.

  4. Sensitive label-free detection of the biomarker phosphorylated tau-217 protein in Alzheimer's disease using a graphene-based solution-gated field effect transistor

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Biosensors & bioelectronics 2023-03-11 Biomarkers

    Alzheimer's disease (AD) is generally diagnosed using advanced imaging, but recent research suggests early screening using biomarkers in peripheral blood is feasible; among them, plasma tau proteins phosphorylated at threonine 231, threonine 181, and threonine 217 (p-tau217) are potential targets.

  5. Development of a biosensor for phosphorylated Tau 181 protein detection in Early-Stage Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Bioelectrochemistry (Amsterdam, Netherlands) 2022-01-14 Biomarkers

    Alzheimer's disease (AD) is the most common form of dementia in the elderly, and there are still no reliable methods for its early detection.

  6. Ultrasensitive assays for detection of plasma tau and phosphorylated tau 181 in Alzheimer's disease: a systematic review and meta-analysis

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. Translational neurodegeneration 2021-03-12 Biomarkers

    A lack of convenient and reliable biomarkers for diagnosis and prognosis is a common challenge for neurodegenerative diseases such as Alzheimer's disease (AD).

  7. Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. PloS one 2014-12-26 Biomarkers

    The character of central nervous system (CNS) HIV infection and its effects on neuronal integrity vary with evolving systemic infection.

All topic tags with their study counts